June 1st, 20232023-06-01Takeda Opens Digital Health Innovation Challenge in Partnership with Plug and Play Alberta for Solutions to Improve Patient Care in Inflammatory Bowel Disease May 11th, 20232023-05-11Takeda Presents Real-World Clinical Effectiveness and Safety Results of Vedolizumab (ENTYVIO®) and Ustekinumab as First-Line Biologic Treatment for Crohn’s Disease All News